NASDAQ:ACHV Achieve Life Sciences (ACHV) Stock Price, News & Analysis → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free ACHV Stock Alerts $4.74 +0.04 (+0.85%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$4.62▼$4.8050-Day Range$4.05▼$4.7452-Week Range$3.03▼$10.30Volume76,066 shsAverage Volume78,845 shsMarket Capitalization$162.17 millionP/E RatioN/ADividend YieldN/APrice Target$17.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Achieve Life Sciences alerts: Email Address Achieve Life Sciences MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside264.3% Upside$17.25 Price TargetShort InterestHealthy2.08% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.44Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.94) to ($0.88) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.58 out of 5 starsMedical Sector3733rd out of 5,424 stocksDiagnostic Substances Industry37th out of 78 stocks 3.5 Analyst's Opinion Consensus RatingAchieve Life Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageAchieve Life Sciences has only been the subject of 3 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.08% of the outstanding shares of Achieve Life Sciences have been sold short.Short Interest Ratio / Days to CoverAchieve Life Sciences has a short interest ratio ("days to cover") of 7.6.Change versus previous monthShort interest in Achieve Life Sciences has recently decreased by 0.59%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldAchieve Life Sciences does not currently pay a dividend.Dividend GrowthAchieve Life Sciences does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ACHV. Previous Next 1.9 News and Social Media Coverage News SentimentAchieve Life Sciences has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Achieve Life Sciences this week, compared to 2 articles on an average week.Search Interest3 people have searched for ACHV on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added Achieve Life Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Achieve Life Sciences insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.00% of the stock of Achieve Life Sciences is held by insiders.Percentage Held by InstitutionsOnly 33.52% of the stock of Achieve Life Sciences is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Achieve Life Sciences are expected to grow in the coming year, from ($0.94) to ($0.88) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Achieve Life Sciences is -3.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Achieve Life Sciences is -3.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. About Achieve Life Sciences Stock (NASDAQ:ACHV)Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.Read More ACHV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ACHV Stock News HeadlinesMay 2, 2024 | americanbankingnews.comAchieve Life Sciences (ACHV) Scheduled to Post Quarterly Earnings on ThursdayApril 28, 2024 | latimes.comWomen Are on Track to Achieve Parity in Gender Representation Among Corporate Leadership Roles as Soon as 2030May 4, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. April 26, 2024 | msn.comAchieve Life Sciences files to sell 13.09M shares of common stock for holdersApril 25, 2024 | globenewswire.comAchieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024April 18, 2024 | nasdaq.comJonesTrading Initiates Coverage of Achieve Life Sciences (ACHV) with Buy RecommendationApril 17, 2024 | finance.yahoo.comAchieve Institute CEO Mark Cunningham Named to the Forbes Business CouncilApril 13, 2024 | msn.comMcNair rolls past College Achieve Paterson - Softball recapMay 4, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. April 11, 2024 | finance.yahoo.comAchieve Life Sciences to Present at Life Science Innovation Northwest 2024 ConferenceApril 4, 2024 | seekingalpha.comAchieve Life Sciences: An Excellent Drug Addressing A Large Market Could Drive 5x ReturnsApril 1, 2024 | finance.yahoo.comACHV: 2023 ResultsMarch 30, 2024 | seekingalpha.comAchieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call TranscriptMarch 29, 2024 | finance.yahoo.comQ4 2023 Achieve Life Sciences Inc Earnings CallMarch 28, 2024 | benzinga.comRecap: Achieve Life Sciences Q4 EarningsMarch 28, 2024 | finance.yahoo.comAchieve Life Sciences Inc Reports Year-End Loss, Progresses Towards FDA ApprovalMarch 28, 2024 | globenewswire.comAchieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate UpdateMarch 28, 2024 | msn.comOptions Volatility and Implied Earnings Moves Today, March 28, 2024March 27, 2024 | msn.comAchieve Life Sciences Q4 2023 Earnings PreviewMarch 20, 2024 | finance.yahoo.comAchieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual MeetingMarch 18, 2024 | bizjournals.comOver $1 million raised for community initiatives, scholarships at Donald Driver's Driven To Achieve Awards: SlideshowMarch 16, 2024 | ca.finance.yahoo.comACHV Apr 2024 2.500 callMarch 14, 2024 | finance.yahoo.comAchieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024March 11, 2024 | msn.comHow AI Is Saving LivesMarch 11, 2024 | nj.comWATCH: No. 12 College Achieve Asbury Park celebrates winning the Group 1 state titleMarch 11, 2024 | msn.comLuka Doncic Creates NBA History; Becomes the First Player to Achieve THIS FeatMarch 10, 2024 | msn.comNo. 12 College Achieve Asbury Park owns Group 1, easily wins title in 1st yearSee More Headlines Receive ACHV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Achieve Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today5/03/2024Next Earnings (Confirmed)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryBiotechnology Current SymbolNASDAQ:ACHV CUSIP68230A10 CIK949858 Webachievelifesciences.com Phone(604) 210-2217Fax425-686-1600Employees22Year FoundedN/APrice Target and Rating Average Stock Price Target$17.25 High Stock Price Target$20.00 Low Stock Price Target$11.00 Potential Upside/Downside+264.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($1.53) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,820,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-936.70% Return on Assets-127.66% Debt Debt-to-Equity Ratio4.02 Current Ratio0.82 Quick Ratio0.82 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / Book-67.64Miscellaneous Outstanding Shares34,250,000Free Float33,567,000Market Cap$162.17 million OptionableOptionable Beta1.26 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesDr. Richard A. B. Stewart (Age 65)Executive Chairman Comp: $575kMr. John A. Bencich M.B.A. (Age 47)CEO & Director Comp: $733.12kDr. Cindy Jacobs M.D. (Age 66)Ph.D., President, Chief Medical Officer & Director Comp: $614.25kMr. Jerry Wan (Age 42)Principal Accounting Officer Dr. Anthony Clarke (Age 68)Chief Scientific Officer Comp: $546kMs. Jaime XinosExecutive Vice President of CommercialMore ExecutivesKey CompetitorsVolitionRxNYSE:VNRXAlpha TeknovaNASDAQ:TKNOARCA biopharmaNASDAQ:ABIOAspira Women's HealthNASDAQ:AWHImmuCellNASDAQ:ICCCView All CompetitorsInsidersJohn BencichBought 5,000 shares on 5/30/2023Total: $27,500.00 ($5.50/share)View All Insider Transactions ACHV Stock Analysis - Frequently Asked Questions Should I buy or sell Achieve Life Sciences stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Achieve Life Sciences in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ACHV shares. View ACHV analyst ratings or view top-rated stocks. What is Achieve Life Sciences' stock price target for 2024? 4 analysts have issued 12 month target prices for Achieve Life Sciences' stock. Their ACHV share price targets range from $11.00 to $20.00. On average, they predict the company's stock price to reach $17.25 in the next twelve months. This suggests a possible upside of 264.3% from the stock's current price. View analysts price targets for ACHV or view top-rated stocks among Wall Street analysts. How have ACHV shares performed in 2024? Achieve Life Sciences' stock was trading at $4.12 at the beginning of the year. Since then, ACHV stock has increased by 14.9% and is now trading at $4.7350. View the best growth stocks for 2024 here. When is Achieve Life Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our ACHV earnings forecast. How can I listen to Achieve Life Sciences' earnings call? Achieve Life Sciences will be holding an earnings conference call on Thursday, May 9th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link. How were Achieve Life Sciences' earnings last quarter? Achieve Life Sciences, Inc. (NASDAQ:ACHV) issued its quarterly earnings data on Thursday, March, 28th. The biopharmaceutical company reported ($0.26) EPS for the quarter, beating analysts' consensus estimates of ($0.32) by $0.06. What ETF holds Achieve Life Sciences' stock? Simplify Propel Opportunities ETF holds 217,845 shares of ACHV stock, representing 1.08% of its portfolio. When did Achieve Life Sciences' stock split? Shares of Achieve Life Sciences reverse split before market open on Friday, July 31st 2020. The 1-20 reverse split was announced on Thursday, July 30th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 30th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Achieve Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Achieve Life Sciences investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Gran Tierra Energy (GTE), Bionano Genomics (BNGO), Novan (NOVN), Aeterna Zentaris (AEZS), Zosano Pharma (ZSAN), CNBX Pharmaceuticals (CNBX), KushCo (KSHB) and Pennsylvania Real Estate Investment Trust (PEI). Who are Achieve Life Sciences' major shareholders? Achieve Life Sciences' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). View institutional ownership trends. How do I buy shares of Achieve Life Sciences? Shares of ACHV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ACHV) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe only AI company you should be looking atBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achieve Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.